Our CEO is live today giving a keynote at Pharma R&D summit
The Telegraph’s Tech4Good hosts our CEO, Microsoft’s Chief Medical Scientist and Babylon’s CEO in a discussion about rewriting healthcare
Our CEO, Noor Shaker, is giving a keynote at Pharma R&D Informatics, Medicinal Chemistry and Cannabinoids Summit. The talk will cover challenges and opportunities for AI in drug discovery and how our platform Rosalind addresses existing challenges open new possibilities for the discovery of novel chemistry.
Our CEO to join Novartis UK CSO in a panel discussion about diversity
Our CEO, Noor Shaker, contributed to an interesting panel discussion for The Telegraph’s Tech4Good conference with leading experts in the field of healthcare and future technology beyond the pandemic.
Glamorous AI participates in BioEurope Digital
On the 11th of November, the PM Society is organising a panel discussion around diversity and inclusion in Pharma and biotech. The panel is chaired by Hassan Chaudhury, the chair of PM Society diversity group and will feature Dr Samin Saeed, Chief Scientific Officer at Novartis UK and our CEO, Noor Shaker. Registration is free and […]
Our CEO speaks to In Vivo on making AI for drug discovery a reality
Over the last week of October, we participated in BioEurope 2020. Although the event went digital this year, we really enjoyed a productive week of meetings with partners and collaborators. We are excited to see such interest in our approach and looking forward to progress our discussions and support drug discovery programs with our unique […]
Our CEO spoke to in Vivo for their Rising Leaders series. The interview covered Noor’s journey that started as a computer scientist in AI and led to computer gaming and eventually becoming a biotech entrepreneur. Noor speaks of her ambitions to revolutionise drug discovery with the power of data and AI and the fulfilling mission […]